Skip to main content

Table 2 Correlated miRNA - gene expression pairs in ESCCa

From: Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis

No.miRNAmiRNA fold changebNo. correlated genesCorrelated geneGene fold changecRhoP-value
1has-miR-1551.733PSMB92.500.57<10E-12
    BTN3A3 /// BTN3A21.700.556.80E-10
    UBE2L61.900.542.20E-09
2hsa-miR-133a0.192SLC2A12.40−0.524.50E-09
    SLC6A81.90−0.527.10E-09
3hsa-miR-135a*0.891BC37295_30.830.532.80E-09
4hsa-miR-1450.291SMC41.20−0.541.50E-09
5hsa-miR-1490.46IFI302.40−0.524.80E-09
    PSME21.70−0.526.30E-09
    GZMA1.50− 0.525.40E-09
    PSMB81.80− 0.546.00E-10
    TRA@ /// TRD@1.10− 0.541.30E-09
    PSMB92.50−0.563.70E-12
6hsa-miR-1500.495CCR71.100.570
    IGHM0.940.541.10E-09
    SELL1.300.524.70E-09
    CCL190.810.526.70E-09
    MS4A11.100.525.80E-09
7hsa-miR-200b1.117GPR1161.10−0.527.40E-09
    DMD0.58−0.534.90E-09
    IL330.61−0.532.60E-09
    RFTN11.20−0.534.30E-09
    PPARGC1A0.71−0.534.70E-09
    GPM6A0.68−0.541.50E-09
    GEM0.80−0.561.40E-10
8hsa-miR-2030.31146DSG30.450.63<10E-12
    CST60.350.62<10E-12
    IL1RN0.160.62<10E-12
    MAP3K90.500.62<10E-12
    GLTP0.280.62<10E-12
    AIM1L /// FLJ380200.290.62<10E-12
    PPL0.170.61<10E-12
    SERPINB130.190.61<10E-12
    FBXO340.570.61<10E-12
    EVPL0.290.60<10E-12
    SPRR1B0.430.60<10E-12
    SERPINB130.220.60<10E-12
    SPRR1A0.270.60<10E-12
    RAPGEFL10.540.60<10E-12
    ZNF7500.290.60<10E-12
    (for full set of genes correlated with miR-203, see Supplementary TableS3)
9hsa-miR-2050.895F121.100.57<10E-12
    STX61.100.541.30E-09
    HSPA40.850.526.90E-09
    MGC240390.97−0.525.60E-09
    PFAAP50.90−0.533.50E-09
10hsa-miR-2141.173CHAF1A1.40−0.524.70E-09
    EZH22.10−0.541.60E-09
    TMPO1.50−0.548.50E-10
11hsa-miR-2241.561F121.100.532.00E-09
12hsa-miR-3200.512ACOX20.500.516.60E-09
    EZH22.10−0.544.40E-10
13hsa-miR-3750.022IL1RN0.160.599.90E-10
    PSG30.620.581.40E-09
14hsa-miR-574–3p0.455ADD10.720.532.30E-09
    GAS70.520.527.00E-09
    EZH22.10−0.527.80E-09
    TMPO1.50−0.525.60E-09
    C13orf341.90−0.524.80E-09
15hsa-miR-6500.9815LOC913161.500.64<10E-12
    POU2AF11.700.60<10E-12
    CTA-246H3.11.800.58<10E-12
    MGC295061.300.58<10E-12
    CD79A1.000.552.50E-10
    IGHA1 /// IGHG1 /// IGHG3 /// IGHM1.200.555.90E-10
    IL81.600.542.10E-09
    IVD1.600.541.20E-09
    CXCL132.800.533.20E-09
    IGL@2.300.533.70E-09
    IGKC /// NTN2L /// GJB62.400.532.60E-09
    IGL@ /// IGLV4–3 /// IGLV3–25 /// IGLV2–14 /// IGLJ32.300.533.10E-09
    IGL@ /// IGLV4–3 /// IGLV3–25 /// IGLV2–142.100.535.10E-09
    HLA-C2.000.526.30E-09
    IGL@ /// IGLV3–25 /// IGLV2–14 /// IGLJ32.100.525.90E-09
16hsa-miR-99b0.791SMC41.20−0.524.40E-09
  1. aP-value threshold for multiple comparison adjustment = P < 8.40E-09 (0.05/5,947,959)
  2. bmedian miRNA fold change
  3. cmean gene expression fold change